"Obesity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Descriptor ID |
D009765
|
| MeSH Number(s) |
C18.654.726.500 C23.888.144.699.500 E01.370.600.115.100.160.120.699.500 G07.100.100.160.120.699.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Obesity".
Below are MeSH descriptors whose meaning is more specific than "Obesity".
This graph shows the total number of publications written about "Obesity" by people in this website by year, and whether "Obesity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 2 | 9 |
| 1997 | 6 | 6 | 12 |
| 1998 | 10 | 7 | 17 |
| 1999 | 15 | 2 | 17 |
| 2000 | 16 | 4 | 20 |
| 2001 | 15 | 1 | 16 |
| 2002 | 19 | 6 | 25 |
| 2003 | 35 | 9 | 44 |
| 2004 | 30 | 20 | 50 |
| 2005 | 35 | 10 | 45 |
| 2006 | 37 | 13 | 50 |
| 2007 | 32 | 13 | 45 |
| 2008 | 41 | 12 | 53 |
| 2009 | 41 | 12 | 53 |
| 2010 | 45 | 25 | 70 |
| 2011 | 60 | 24 | 84 |
| 2012 | 67 | 23 | 90 |
| 2013 | 89 | 42 | 131 |
| 2014 | 59 | 27 | 86 |
| 2015 | 61 | 27 | 88 |
| 2016 | 52 | 26 | 78 |
| 2017 | 66 | 21 | 87 |
| 2018 | 46 | 19 | 65 |
| 2019 | 43 | 18 | 61 |
| 2020 | 42 | 33 | 75 |
| 2021 | 35 | 48 | 83 |
| 2022 | 12 | 59 | 71 |
| 2023 | 16 | 52 | 68 |
| 2024 | 31 | 32 | 63 |
| 2025 | 38 | 11 | 49 |
| 2026 | 11 | 5 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Obesity" by people in Profiles.
-
Adverse effect of obesity and dysglycemia on bone microarchitecture and strength in youth: sex-related differences. J Clin Endocrinol Metab. 2026 Jul 15; 111(8):e1983-e1993.
-
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial. Lancet. 2026 Jun 20; 407(10547):2503-2514.
-
Obesity in CKD: Core Curriculum 2026. Am J Kidney Dis. 2026 Jul; 88(1):142-153.
-
Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study. J Clin Endocrinol Metab. 2026 May 19; 111(6):1613-1627.
-
Selective and differential roles of PVHCRH neurotransmitters in diet-induced obesity in mice. Nat Commun. 2026 May 13; 17(1).
-
A 2-year randomized trial of pitavastatin calcium vs placebo to treat combined dyslipidemia in adolescents with overweight and obesity. J Clin Lipidol. 2026 Jun; 20(6):1212-1235.
-
Geroprotective effects of diet and exercise plus metformin in frail older veterans with obesity: The DEMFOS randomized trial protocol. Contemp Clin Trials. 2026 Jun; 165:108321.
-
Fructose: metabolic signal and modern hazard. Nat Metab. 2026 May; 8(5):1019-1033.
-
High-fat diet causes rapid loss of intestinal group 3 innate lymphoid cells through microbiota-driven inflammation and mitochondrial stress. Immunity. 2026 Apr 14; 59(4):988-1005.e9.
-
Obesity supersizes macrophage and neutrophil activation after stroke while lipid droplets play a protective role. J Neuroinflammation. 2026 Mar 19; 23(1).